https://www.barrons.com/articles/madrigal-pharmaceuticals-stock-price-resmetirom-news-51671474714
0
0
12/19/22 at 9:08pm
Organization
Barron's
Author
Josh Nathan-Kazis
31 words
0
Comments
A late-stage trial of its drug resmetirom showed a 'best-case dataset' in resolving NASH and improving liver fibrosis.
You are the first to view
Create an account
or login to join the discussion